<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Social Medicine</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D59770D7-7527-43D2-B0C3-96E0FEEAFF25"><gtr:id>D59770D7-7527-43D2-B0C3-96E0FEEAFF25</gtr:id><gtr:firstName>Malcolm</gtr:firstName><gtr:surname>Price</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=ES%2FJ002909%2F1"><gtr:id>8B40617B-F7FB-413D-917C-B8090DD851D6</gtr:id><gtr:title>Estimation of Markov models for economic models</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>ES/J002909/1</gtr:grantReference><gtr:abstractText>&lt;p>Markov models play a key role in modelling the medium and longer term effects of policy interventions in both health and social science.They also feature prominently in cost-effectiveness analyses. At the same time policy makers and the public require that government strategies are ?evidence based?. The process by which ?evidence? comes to inform a Markov model is, however, far from straightforward and the methods used are often ad-hoc. Malcolm Price?s doctoral research developed a more structured methodological framework for using data to inform Markov models used for cost-effectiveness analysis.&lt;/p>

&lt;p>During this fellowship Malcolm will expand on the methods and fully disseminate them. Upon completion of the proposed series of papers readers should have the necessary methodological tools to be able to combine a wide variety of data types to estimate Markov models correctly. The methods facilitate economic analysis and demonstrate how to perform estimation, cost-effectiveness analysis and assess the value of conducting further research within a single integrated program ensuring that uncertainty in the data is accurately propagated throughout the model. Finally, Malcolm will write a research proposal to develop the methods for use with the more complex models that are required when interventions for infectious diseases are assessed.&lt;/p></gtr:abstractText><gtr:fund><gtr:end>2012-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/924BE15C-91F2-4AAD-941A-3F338324B6AE"><gtr:id>924BE15C-91F2-4AAD-941A-3F338324B6AE</gtr:id><gtr:name>ESRC</gtr:name></gtr:funder><gtr:start>2011-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>74822</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Methodology workshop on Expected Value of information Calculations run by the Medical Research Council Conduct-II hub for Trials Methodology Research.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8811B979-3F84-4EF9-9FB4-5E4D1433E58C</gtr:id><gtr:impact>The workshop summarized the state of the field of Value of information methodology and highlighted the key areas for further methodological developement</gtr:impact><gtr:outcomeId>58c96de6918b31.02859591</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8863B14A-C681-43AF-A5FD-6B69DFD28C7C</gtr:id><gtr:title>Strategies for efficient computation of the expected value of partial perfect information.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13645c07a180a522f538980c4be6a5f6"><gtr:id>13645c07a180a522f538980c4be6a5f6</gtr:id><gtr:otherNames>Madan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn><gtr:outcomeId>58a9fa7b2d2809.28334392</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3F84376-C03D-48D5-9854-B9D1A550DA7F</gtr:id><gtr:title>Mixture-of-exponentials models to explain heterogeneity in studies of the duration of Chlamydia trachomatis infection.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5f8e247f0398fb1f6fc73be32a5ab2"><gtr:id>6b5f8e247f0398fb1f6fc73be32a5ab2</gtr:id><gtr:otherNames>Price MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn><gtr:outcomeId>58a9f97a38a867.60470045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60DA9627-FF1F-49FB-AE6A-B15D5FF7DA3F</gtr:id><gtr:title>Incidence of Chlamydia trachomatis infection in women in England: two methods of estimation.</gtr:title><gtr:parentPublicationTitle>Epidemiology and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5f8e247f0398fb1f6fc73be32a5ab2"><gtr:id>6b5f8e247f0398fb1f6fc73be32a5ab2</gtr:id><gtr:otherNames>Price MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-2688</gtr:issn><gtr:outcomeId>5675d8705dac8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCAD87B7-DEB7-4FE1-B313-5B21976168D0</gtr:id><gtr:title>How much tubal factor infertility is caused by Chlamydia? Estimates based on serological evidence corrected for sensitivity and specificity.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5f8e247f0398fb1f6fc73be32a5ab2"><gtr:id>6b5f8e247f0398fb1f6fc73be32a5ab2</gtr:id><gtr:otherNames>Price MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>58a9f9e468a990.74764515</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8586A43D-9C8E-4230-B813-59003F4EA971</gtr:id><gtr:title>Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5f8e247f0398fb1f6fc73be32a5ab2"><gtr:id>6b5f8e247f0398fb1f6fc73be32a5ab2</gtr:id><gtr:otherNames>Price MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>58a9f9e43be062.91462765</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">ES/J002909/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>7D5D2DB2-0A64-42AF-A644-5F541B832A29</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Economics</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>7D5D2DB2-0A64-42AF-A644-5F541B832A29</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Economics</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>FFA3A6C9-532B-4B83-B6F7-AAF3E63D34F0</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Social Stats., Comp. &amp; Methods</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>